MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Key developments

Multiple Sclerosis in 2025 – Key Developments to Date

MStranslate
May 7, 2025
Cambridge, ECTRIMS, Remyelination, Research
The ECTRIMS Podcast

UPDATED: The ECTRIMS Podcast – Episode Library

MStranslate
March 22, 2025
ECTRIMS, Podcasts, Research
1 Comment
diet multiple sclerosis

Diet & Clinical Outcomes in Multiple Sclerosis

MStranslate
November 13, 2024
Diet, Lifestyle, Research
microglia

Study Provides New Insights Into Disease Progression

MStranslate
November 6, 2024
Research
ECTRIMS 2024

ECTRIMS 2024: An Overview

MStranslate
October 14, 2024
ECTRIMS, Events, Podcasts

Bile Acids: A Novel Multiple Sclerosis Therapy?

MStranslate
August 6, 2024
Research, Treatments
Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are constantly looking at novel approaches for the treatment of...
HSCT

Long-term HSCT Outcomes in Norway

MStranslate
July 9, 2024
Research, Stem Cells, Treatments
Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a new treatment approach, haematopoietic stem cell...
wearing off

‘Wearing Off’ Of MS Treatments Between Doses

MStranslate
July 1, 2024
Research, Treatments
Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...
retinoic acid and calcitriol

Retinoic Acid and Calcitriol May Promote Remyelination

MStranslate
June 25, 2024
Remyelination, Research, Treatments
Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
Cambridge Clinical Multiple Sclerosis Research

Announcement: MS Research Comms Collaboration

MStranslate
May 15, 2024
Cambridge, Collaboration, Research
We are excited to announce that MStranslate has established a new science communication collaboration with the Cambridge Clinical Multiple Sclerosis Research Group, based at the University of Cambridge in...
Vitamin B12

Is Vitamin B12 Important in Multiple Sclerosis?

MStranslate
December 20, 2023
Fingolimod, Research, Vitamin B12
2 Comments
Research Summary: FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis The treatment of multiple sclerosis has improved greatly over the...
BTK

BTK Inhibitors in the Treatment of MS

MStranslate
December 12, 2023
Clinical Trials, Research, Treatments
What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells.  B cells, which are important cells in the immune system,...
MS Milan 2023 Podcast

The MS Milan 2023 Podcast: Daily Episodes

MStranslate
November 16, 2023
Conferences, ECTRIMS, Podcasts
Following the success of The ECTRIMS Podcast 2022 and its subsequent episodes throughout 2023, the European Committee for Treatment and Research in Multiple Sclerosis organisation once again invited our...
MS Milan 2023

MS Milan 2023: Daily Research Summary Videos

MStranslate
October 19, 2023
ACTRIMS, ECTRIMS, Research
1 Comment
MS Milan 2023 was the 9th Joint ECTRIMS-ACTRIMS Meeting, coordinated by the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and...
An image of the human brain with nerve cells firing and then a zoomed in image of a nerve with impulses going off in various directions

Clemastine Repairs Damage In Multiple Sclerosis

MStranslate
July 4, 2023
Clinical Trials, Neuroimaging, Remyelination
Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is the next big step in the treatment of multiple sclerosis. ...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview

Recent Comments

  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS
  • Bile Acids: A Novel Multiple Sclerosis Therapy? on Bile Acids May Play Role in Multiple Sclerosis
  • MStranslate on Is Vitamin B12 Important in Multiple Sclerosis?
  • MStranslate on Facebook Live: Diet Outcomes in Multiple Sclerosis
  • A on Facebook Live: Diet Outcomes in Multiple Sclerosis

Calendar

May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Mar    

Archives

  • May 2025
  • March 2025
  • November 2024
  • October 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • July 2023
  • March 2023
  • January 2023
  • November 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • March 2013
  • February 2013
  • December 2012
  • October 2012

Categories

  • AAN
  • ACTRIMS
  • Alemtuzumab
  • B Cells
  • Basic Sciences
  • Behind the Scenes
  • Biotin
  • Cambridge
  • CCSVI
  • Clinical Trials
  • Cognition
  • Collaboration
  • Community
  • Conferences
  • COVID-19
  • Daclizumab
  • Diet
  • Dimethyl fumarate
  • Dr Sally Shaw
  • Dr Travis Stiles
  • ECTRIMS
  • Epstein-Barr virus
  • Events
  • Exercise
  • Fatigue
  • Feedback
  • Fingolimod
  • Genetics
  • Google Hangouts
  • Gut microbiome
  • Hormones
  • Infection
  • Interferon-beta
  • Laquinimod
  • Lifestyle
  • Medicinal Cannabis
  • Mental Health
  • MIS416
  • Movement Disorders
  • MS Virtual
  • MS: Many Stories
  • MStranslate
  • Natalizumab
  • Neuroimaging
  • Ocrelizumab
  • Ocular Motor
  • Opinion
  • Podcasts
  • Presentations
  • Progressive MS
  • Q&A
  • Quality of Life
  • Recruitment
  • Rehabilitation
  • Remyelination
  • Research
  • Rituximab
  • Social Media
  • Stem Cells
  • Symposium
  • Symptoms
  • Treatments
  • Type 1 Diabetes
  • Uncategorized
  • Understanding Science
  • Videos
  • Vitamin B12
  • Vitamin D

Posts

  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkValues & Standards